Caris Life Sciences, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $181,398 | $120,915 | $100,049 | $80,677 |
Gross Profit | 113,685 | 57,063 | 37,554 | 26,114 |
EBITDA | -46,173 | -82,754 | -40,902 | -84,033 |
EBIT | -52,582 | -89,799 | -52,512 | -101,738 |
Net Income | -71,790 | -102,581 | -66,186 | -111,028 |
Net Change In Cash | 181,398 | 120,915 | 100,049 | 80,677 |
Free Cash Flow | 5,902 | -34,027 | -65,514 | -75,663 |
Cash | 718,934 | 31,201 | ||
Basic Shares | 64,918 | 254,788 | 254,788 | 254,788 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $412,260 | $306,128 | $258,485 | $294,013 |
Gross Profit | 178,782 | 89,310 | 80,022 | 184,157 |
EBITDA | -182,952 | -260,804 | -245,894 | 201,748 |
EBIT | -231,865 | -309,805 | -294,147 | 91,098 |
Net Income | -281,890 | -341,415 | -320,827 | 27,733 |
Net Change In Cash | 412,260 | 306,128 | 258,485 | 294,013 |
Free Cash Flow | -253,643 | -298,419 | -327,961 | 57,566 |
Cash | 63,950 | 56,402 | 107,191 | 53,547 |
Basic Shares | 254,662 | 254,662 | 254,788 | 17,949 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$1.11 |
